GENERAL ATLANTIC, L.P. - Q1 2019 holdings

$1.2 Billion is the total value of GENERAL ATLANTIC, L.P.'s 5 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was - .

 Value Shares↓ Weighting
SAIC NewSCIENCE APPLICATIONS INTERNATIONAL CORP.$310,278,0004,032,200
+100.0%
25.94%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-05-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
XP, INC19Q2 202478.5%
ROYALTY PHARMA17Q2 20242.2%
ENGILITY HOLDINGS INC16Q4 201825.0%
CHINA INDEX HOLDINGS16Q1 20232.0%
58.COM INC15Q2 202039.3%
ARCO PLATFORM LTD15Q3 202332.7%
OPENDOOR TECHNOLOGIES INC15Q2 20245.5%
ALIGNMENT HEALTHCARE14Q2 202419.6%
PHARVARIS14Q2 20244.5%
IMMUNOCORE14Q2 20242.3%

View GENERAL ATLANTIC, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)
GENERAL ATLANTIC, L.P. Q1 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
HireRight Holdings CorpSold outJune 28, 202400.0%
Akero Therapeutics, Inc.March 15, 20245,233,9897.7%
Immunocore Holdings plcMarch 07, 20241,747,8493.5%
Blend Labs, Inc.February 13, 202419,132,4408.0%
BuzzFeed, Inc.Sold outFebruary 13, 202400.0%
Clear Secure, Inc.Sold outFebruary 13, 202400.0%
Grove Collaborative Holdings, Inc.February 13, 20242,710,0258.2%
Mobileye Global Inc.February 13, 20241,318,7821.4%
Pharvaris N.V.February 13, 20247,531,25214.1%
Royalty Pharma plcFebruary 13, 202426,259,1415.6%

View GENERAL ATLANTIC, L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-09-18
SC 13D/A2024-09-11
N-PX2024-09-03
13F-HR2024-08-14
42024-08-12
42024-06-28
SC 13D/A2024-06-28
42024-06-10
42024-06-06
SC 13D2024-05-20

View GENERAL ATLANTIC, L.P.'s complete filings history.

Compare quarters

Export GENERAL ATLANTIC, L.P.'s holdings